Page 2059 - Hematology_ Basic Principles and Practice ( PDFDrive )
P. 2059
1828 Part XI Transfusion Medicine
editors: Handbook of Pediatric Transfusion Medicine, London, 2004, 29. Eder AF: Review: acute Donath-Landsteiner hemolytic anemia. Immu-
Elsevier Academic Press, pp 181–189. nohematology 21(2):56–62, 2005.
17. Meliones JN, Hansell DR: Extracorporeal membrane oxygenation: The 30. Bolan CD, Yau YY, Cullis HC, et al: Pediatric large-volume leukapher-
role of blood components. In Chambers LA, Isssitt LA, editors: Support- esis: a single institution experience with heparin versus citrate-based
ing the pediatric transfusion recipient, Bethesda, MD, 1994, AABB, pp anticoagulant regimens. Transfusion 44(2):229–238, 2004.
87–107. 31. Gilbert GL, Hayes K, Hudson IL, et al: Prevention of transfusion-
18. Hendrickson JE, Shaz BH, Pereira G, et al: Coagulopathy is prevalent acquired cytomegalovirus infection in infants by blood filtration to
and associated with adverse outcomes in transfused pediatric trauma remove leucocytes. Neonatal Cytomegalovirus Infection Study Group.
patients. J Pediatr 160(2):204–209 e3, 2012. Lancet 1(8649):1228–1231, 1989.
19. Holcomb JB, Tilley BC, Baraniuk S, et al: Transfusion of plasma, 32. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent
platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality alloimmunization and refractoriness to platelet transfusions. The Trial
in patients with severe trauma: the PROPPR randomized clinical trial. to Reduce Alloimmunization to Platelets Study Group. N Engl J Med
JAMA 313(5):471–482, 2015. 337(26):1861–1869, 1997.
20. Dehmer JJ, Adamson WT: Massive transfusion and blood product use in 33. Fergusson D, Hebert PC, Lee SK, et al: Clinical outcomes following
the pediatric trauma patient. Semin Pediatr Surg 19(4):286–291, 2010. institution of universal leukoreduction of blood transfusions for prema-
21. Adams RJ, Brambilla D: Discontinuing prophylactic transfusions used to ture infants. JAMA 289(15):1950–1956, 2003.
prevent stroke in sickle cell disease. N Engl J Med 353(26):2769–2778, 34. Josephson CD, Caliendo AM, Easley KA, et al: Blood transfusion and
2005. breast milk transmission of cytomegalovirus in very low-birth-weight
22. Adams RJ, McKie VC, Hsu L, et al: Prevention of a first stroke by infants: a prospective cohort study. JAMA Pediatr 168(11):1054–1062,
transfusions in children with sickle cell anemia and abnormal results on 2014.
transcranial Doppler ultrasonography. N Engl J Med 339(1):5–11, 1998. 35. Yeager AS, Grumet FC, Hafleigh EB, et al: Prevention of transfusion-
23. Vichinsky EP, Luban NL, Wright E, et al: Prospective RBC phenotype acquired cytomegalovirus infections in newborn infants. J Pediatr
matching in a stroke-prevention trial in sickle cell anemia: a multicenter 98(2):281–287, 1981.
transfusion trial. Transfusion 41(9):1086–1092, 2001. 36. Vamvakas EC: Is white blood cell reduction equivalent to antibody
24. Castro O, Sandler SG, Houston-Yu P, et al: Predicting the effect of trans- screening in preventing transmission of cytomegalovirus by transfu-
fusing only phenotype-matched RBCs to patients with sickle cell disease: sion? A review of the literature and meta-analysis. Transfus Med Rev
theoretical and practical implications. Transfusion 42(6):684–690, 2002. 19(3):181–199, 2005.
25. Chou ST, Jackson T, Vege S, et al: High prevalence of red blood cell allo- 37. Laupacis A, Brown J, Costello B, et al: Prevention of posttransfusion
immunization in sickle cell disease despite transfusion from Rh-matched CMV in the era of universal WBC reduction: a consensus statement.
minority donors. Blood 122(6):1062–1071, 2013. Transfusion 41(4):560–569, 2001.
26. Olivieri NF: The beta-thalassemias. N Engl J Med 341(2):99–109, 1999. 38. Josephson CD, Castillejo MI, Grima K, et al: ABO-mismatched platelet
27. Vichinsky E, Neumayr L, Trimble S, et al: Transfusion complications in transfusions: strategies to mitigate patient exposure to naturally occurring
thalassemia patients: a report from the Centers for Disease Control and hemolytic antibodies. Transfus Apher Sci 42(1):83–88, 2010.
Prevention (CME). Transfusion 54(4):972–981, quiz 1, 2014. 39. Bada HS, Chua C, Salmon JH, et al: Changes in intracranial pressure
28. Aladjidi N, Leverger G, Leblanc T, et al: New insights into childhood during exchange transfusion. J Pediatr 94(1):129–132, 1979.
autoimmune hemolytic anemia: a French national observational study
of 265 children. Haematologica 96(5):655–663, 2011.

